Compare TACT & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TACT | UG |
|---|---|---|
| Founded | 1996 | 1942 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.2M | 30.2M |
| IPO Year | 1996 | 1995 |
| Metric | TACT | UG |
|---|---|---|
| Price | $3.23 | $6.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 57.1K | 2.9K |
| Earning Date | 03-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 7.78% |
| EPS Growth | ★ 87.88 | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $12,181,971.00 |
| Revenue This Year | $10.36 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.50 |
| Revenue Growth | N/A | ★ 11.91 |
| 52 Week Low | $3.06 | $5.58 |
| 52 Week High | $5.70 | $9.88 |
| Indicator | TACT | UG |
|---|---|---|
| Relative Strength Index (RSI) | 39.97 | 44.69 |
| Support Level | N/A | $6.31 |
| Resistance Level | $3.87 | $6.78 |
| Average True Range (ATR) | 0.27 | 0.13 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 26.09 | 20.76 |
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.